1. Academic Validation
  2. Discovery of 3,4-Dihydropyrimidin-2(1H)-ones As a Novel Class of Potent and Selective A2B Adenosine Receptor Antagonists

Discovery of 3,4-Dihydropyrimidin-2(1H)-ones As a Novel Class of Potent and Selective A2B Adenosine Receptor Antagonists

  • ACS Med Chem Lett. 2013 Oct 3;4(11):1031-6. doi: 10.1021/ml400185v.
Abel Crespo 1 Abdelaziz El Maatougui 1 Pierfrancesco Biagini 2 Jhonny Azuaje 1 Alberto Coelho 1 José Brea 2 María Isabel Loza 2 María Isabel Cadavid 2 Xerardo García-Mera 2 Hugo Gutiérrez-de-Terán 3 Eddy Sotelo 4
Affiliations

Affiliations

  • 1 Center for Research in Biological Chemistry and Molecular Materials (CIQUS), Institute of Industrial Pharmacy, Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela , Santiago de Compostela 15782, Spain ; Center for Research in Biological Chemistry and Molecular Materials (CIQUS), Institute of Industrial Pharmacy, Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela , Santiago de Compostela 15782, Spain.
  • 2 Center for Research in Biological Chemistry and Molecular Materials (CIQUS), Institute of Industrial Pharmacy, Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela , Santiago de Compostela 15782, Spain.
  • 3 Department of Cell and Molecular Biology, Uppsala University, Biomedical Center , Uppsala SE-75124, Sweden.
  • 4 Center for Research in Biological Chemistry and Molecular Materials (CIQUS), Institute of Industrial Pharmacy, Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela , Santiago de Compostela 15782, Spain ; Center for Research in Biological Chemistry and Molecular Materials (CIQUS), Institute of Industrial Pharmacy, Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela , Santiago de Compostela 15782, Spain ; Center for Research in Biological Chemistry and Molecular Materials (CIQUS), Institute of Industrial Pharmacy, Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela , Santiago de Compostela 15782, Spain.
Abstract

We describe the discovery and optimization of 3,4-dihydropyrimidin-2(1H)-ones as a novel family of (nonxanthine) A2B receptor antagonists that exhibit an unusually high selectivity profile. The Biginelli-based hit optimization process enabled a thoughtful exploration of the structure-activity and structure-selectivity relationships for this chemotype, enabling the identification of ligands that combine structural simplicity with excellent hA2B AdoR affinity and remarkable selectivity profiles.

Keywords

3,4-dihydropyrimidin-2(1H)-ones; A2B receptor antagonists; Adenosine antagonists; Biginelli reaction.

Figures
Products